The Exportin-1 Inhibitor Selinexor Exerts Superior Antitumor Activity when Combined with T-Cell Checkpoint Inhibitors. [electronic resource]
Producer: 20170629Description: 417-427 p. digitalISSN:- 1538-8514
- Animals
- Antibodies, Monoclonal -- pharmacology
- Antineoplastic Agents -- pharmacology
- B7-H1 Antigen -- antagonists & inhibitors
- CTLA-4 Antigen -- antagonists & inhibitors
- Cell Line, Tumor
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Drug Synergism
- Humans
- Hydrazines -- pharmacology
- Immunomodulation -- drug effects
- Karyopherins -- antagonists & inhibitors
- Melanoma, Experimental
- Mice
- Neoplasms -- drug therapy
- Receptors, Cytoplasmic and Nuclear -- antagonists & inhibitors
- T-Lymphocytes -- drug effects
- Triazoles -- pharmacology
- Exportin 1 Protein
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.